John G. Emery
- Molecular Biology top 5%
- Immunology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Epidemiology
- Co-authors
- Peter R. YoungKeith C. DeenSally D. LynPeter McDonnellRobert A. DoddsMartin RosenbergCarol SilvermanEdward R. Appelbaum
- Topics
- Immune Response and Inflammation (5 papers)NF-κB Signaling Pathways (4 papers)Cancer-related gene regulation (3 papers)
- Cited by
- ImmunologyCancer ResearchOncology
- Partner nations
- United StatesIrelandGermany
In The Last Decade
John G. Emery
20 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Molecular Biology 1.4k
- Immunology 702
- Oncology 611
- Cancer Research 433
- Epidemiology 168
Countries citing papers authored by John G. Emery
This map shows the geographic impact of John G. Emery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Emery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Emery more than expected).
Fields of papers citing papers by John G. Emery
This network shows the impact of papers produced by John G. Emery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Emery. The network helps show where John G. Emery may publish in the future.
Co-authorship network of co-authors of John G. Emery
This figure shows the co-authorship network connecting the top 25 collaborators of John G. Emery. A scholar is included among the top collaborators of John G. Emery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Emery. John G. Emery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 7 | |
| 3 | 100 | |
| 4 | 2 | |
| 5 | 24 | |
| 6 | 66 | |
| 7 | 17 | |
| 8 | 44 | |
| 9 | 16 | |
| 10 | 28 | |
| 11 | 64 | |
| 12 | 1 | |
| 13 | 20 | |
| 14 | 26 | |
| 15 | Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAILbreakdown → | 989 |
| 16 | 196 | |
| 17 | 229 | |
| 18 | 74 | |
| 19 | 23 | |
| 20 | 93 |
About John G. Emery
John G. Emery is a scholar working on Cancer Research, Clinical Biochemistry and Immunology, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Immune Response and Inflammation (5 papers), NF-κB Signaling Pathways (4 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Immunology (702 citations), Cancer Research (433 citations) and Oncology (611 citations). John G. Emery has collaborated with scholars based in United States, Ireland and Germany. Frequent co-authors include Peter R. Young, Keith C. Deen, Sally D. Lyn, Peter McDonnell, Robert A. Dodds, Martin Rosenberg, Carol Silverman, Edward R. Appelbaum, Edward Dul and Ian E. James. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.